Greetings,
Does anyone have guidance on how best to report quality and accuracy of NGS (overall, and for specific regions) for a clinical application?
Thanks
Greetings,
Does anyone have guidance on how best to report quality and accuracy of NGS (overall, and for specific regions) for a clinical application?
Thanks
This is so far the best resource I've found on this topic: https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm509838.pdf
Thanks for the comments.
Another relevant reference is the FHIR Genomics "Sequence" resource [https://hl7.org/fhir/genomics.html#sequence], which has fields for the quality of NGS data, and is aligning with the FDA's draft recommendations.
So, perhaps through HL7 there is an evolving way to communicate the quality data to an electronic health record in a standard way, and perhaps multiple streams of thought are converging on an agreed upon set of metrics for expressing the quality, but I'm still fuzzy on just where the quality data will come from (e.g. will the lab make it available).
Hello bdolin,
FastQC serves your purpose very well.
FastQC aims to provide a simple way to do some quality control checks on raw sequence data coming from high throughput sequencing pipelines. It provides a modular set of analyses which you can use to give a quick impression of whether your data has any problems of which you should be aware before doing any further analysis.
The main functions of FastQC are
Import of data from BAM, SAM or FastQ files (any variant)
Providing a quick overview to tell you in which areas there may be problems
Summary graphs and tables to quickly assess your data
Export of results to an HTML based permanent report
Offline operation to allow automated generation of reports without running the interactive application
Use the following link for further reading.
cheers
Optimist
While FastQC is fine for general purpose sequencing QC, following important bit from the original posting needs to be considered.
for a clinical application
I don't think final recommendations for NGS data have been put out by FDA (which may be applicable to US but I assume are widely copied by other regulatory agencies).
Edit: I am not sure if OP added this important bit sometime after @h.mon wrote the comment above but it is there now.
As per the article here on linkedin (https://www.linkedin.com/pulse/evolving-standards-clinical-ngs-akanksha-wattal ), CDC and CAP (both, i guess are in US) require certain quality measures for clinical NGS. Refer to Table 2. But tools accepted are not listed in the article.
Try AfterQC, it offers:
It is available at: https://github.com/OpenGene/AfterQC
Here is a report sample: http://opengene.org/AfterQC/report.html
Use of this site constitutes acceptance of our User Agreement and Privacy Policy.
First step: read How To Ask Good Questions On Technical And Scientific Forums.
Second step: use some general purpose quality-checking software, like FastQC.
Third step: use some targeted quality-checking, it will depend on type of material (RNA, DNA, tissue, cell line, whatever), library prep, sequencing technology, and so on. To narrow it down a bit, mapping metrics would be useful.